[ad_1]
Reuters
Britain’s “AstraZeneca” acquires American “Alexion” for $ 39 billion
The British company “AstraZeneca” has agreed to buy the American pharmaceutical company “Alexion” for 39 billion dollars as part of its largest transaction ever.
This decision would strengthen its position in the field of immunology and rare diseases.
The British company said on Saturday that Alexion shareholders would receive $ 60 in cash and a stake of $ 115 per share.
“This is a great opportunity for us to accelerate our development in the field of immunology, to enter a new category of diseases and to treat a new segment of doctors and patients that we have not been able to cover », Said Pascal Soriot, CEO of AstraZeneca.
The deal comes after “AstraZeneca” said it was conducting more research to determine whether its “Covid-19” vaccine could be 90% effective, which could delay its launch date.
Source: Reuters
[ad_2]
Source link
